This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
ILD medications: acetylcysteine
ILD_ASETYLCYSTEINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
402 |
4. Check minimum number of events
Min. number of events
3
|
402 |
5. Include endpointsNone |
402 |
6. Filter based on genotype QC (FinnGen only) |
357 |
Control definitions (FinnGen only)
- Control exclude
- ILD_MEDICATIONS
Extra metadata
- First used in FinnGen datafreeze
- DF2
ILD medications: acetylcysteine
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 357 | 152 | 205 |
| Unadjusted period prevalence (%) | 0.08 | 0.05 | 0.09 |
| Median age at first event (years) | 61.55 | 53.77 | 67.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 367
- Matched controls
- 3670
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R05CB01
ATC
acetylcysteine; inhalant, oral
+∞
307.7
367
27
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
18.8
188.5
222
276
R03AC12
ATC
salmeterol; inhalant
35.4
185.6
127
54
R03DA04
ATC
theophylline; systemic, rectal
16.4
144.2
150
148
R03BB01
ATC
ipratropium bromide; inhalant
16.8
133.3
132
119
H02AB06
ATC
prednisolone; systemic
10.6
110.6
262
697
H02AB07
ATC
prednisone; oral
13.4
107.6
120
128
R03AK06
ATC
salmeterol and fluticasone; inhalant
11.0
105.4
145
206
R03BA05
ATC
fluticasone; inhalant
10.4
104.2
154
239
R03AK03
ATC
[U] fenoterol and ipratropium bromide
11.5
103.7
134
175
H02AB04
ATC
methylprednisolone; systemic
11.4
93.5
117
145
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
8.8
91.7
158
289
J45.9
ICD-10 Finland
Asthma, unspecified
9.5
91.1
139
221
R03BA02
ATC
budesonide; inhalant
9.0
86.3
139
234
R03BA01
ATC
beclometasone; inhalant
8.8
77.9
122
197
J45.1
ICD-10 Finland
Nonallergic asthma
14.9
72.2
69
56
R03AC03
ATC
terbutaline; inhalant
8.2
64.5
102
164
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
18.5
60.1
50
31
R03DC03
ATC
montelukast; oral
8.4
59.9
90
136
R03AC13
ATC
formoterol; inhalant
11.8
56.5
62
62
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
9.2
55.2
75
100
J45.0
ICD-10 Finland
Predominantly allergic asthma
13.9
54.3
53
44
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
15.6
53.8
49
36
R03BB04
ATC
tiotropium bromide; inhalant
6.9
53.6
99
186
R03AC02
ATC
salbutamol; inhalant
4.9
48.1
243
1048
J01FA06
ATC
roxithromycin; oral
3.8
35.1
202
897
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
7.2
32.5
52
82
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
52.8
32.2
38
8
J01AA02
ATC
doxycycline; systemic
5.6
30.7
322
2063
R05CB02
ATC
bromhexine; systemic
10.1
29.6
35
38
J46
ICD-10 Finland
Status asthmaticus
44.1
29.6
36
9
R03AK07
ATC
formoterol and budesonide; inhalant
4.5
28.3
81
217
J96.1
ICD-10 Finland
Chronic respiratory failure
11.2
27.5
30
29
R03DC01
ATC
zafirlukast; oral
27.3
27.2
37
15
R01AD08
ATC
fluticasone; nasal
3.6
25.6
109
385
J45
ICD-10 Finland
Asthma
5.5
21.0
43
86
J01FA10
ATC
azithromycin; systemic
2.8
20.4
177
921
R05CB03
ATC
carbocisteine; oral
7.3
20.3
31
46
J01FA09
ATC
clarithromycin; systemic
3.1
20.1
110
446
J45.8
ICD-10 Finland
Mixed asthma
24.2
19.4
27
12
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
19.1
82
287
A01AB09
ATC
miconazole; local oral
3.9
19.1
62
180
J01DA06
ATC
[U] cefuroxime
3.6
18.8
72
234
A01AB10
ATC
natamycin; local oral
6.9
18.2
29
45
J47
ICD-10 Finland
Bronchiectasis
17.7
18.2
28
17
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
18.1
169
899
J01MA14
ATC
moxifloxacin; systemic
4.4
18.1
49
124
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.0
17.7
95
378
R06AE07
ATC
cetirizine; oral
2.7
17.7
145
722
R05FB02
ATC
cough suppressants and expectorants; systemic
2.6
17.6
187
1055
A01AB04
ATC
amphotericin B; local oral
4.8
17.3
41
93
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
52.7
17.2
20
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.1
16.1
47
126
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.7
16.0
57
176
J01DA01
ATC
[U] cefalexin
2.6
15.9
248
1645
49300
ICD-8 Finland
Asthma, bronchiale
12.0
15.5
28
25
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.4
14.8
30
59
J01FA01
ATC
erythromycin; systemic
3.6
14.6
54
170
R01BA52
ATC
pseudoephedrine, combinations; oral
2.6
14.1
99
450
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
21.1
13.9
20
10
L01BA01
ATC
methotrexate; systemic
78.1
13.7
15
*
A07AA02
ATC
nystatin; oral
4.2
13.6
38
98
R05DA20
ATC
opium alkaloids and derivatives - combinations
2.5
13.4
107
515
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
13.4
159
914
J01FA15
ATC
telithromycin; oral
4.2
13.3
37
95
R03BB02
ATC
oxitropium bromide; inhalant
17.5
13.1
20
12
A02BA04
ATC
nizatidine; systemic
3.3
12.9
54
184
A02BA02
ATC
ranitidine; systemic
2.4
12.8
112
561
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
16.2
12.8
20
13
R96
ICPC
Asthma
4.0
12.6
37
99
J01DA08
ATC
[U] cefaclor
3.9
12.1
37
102
N05BA01
ATC
diazepam; systemic, rectal
2.8
12.0
66
263
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
67.2
11.7
13
*
J02AC01
ATC
fluconazole; systemic
2.3
11.6
124
675
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
12.4
11.5
20
17
M05BA04
ATC
alendronic acid; oral
3.1
11.3
51
181
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.8
11.2
35
98
R05DB05
ATC
pentoxyverine; oral, rectal
4.9
11.1
25
54
R03BC03
ATC
nedocromil; inhalant
3.8
10.9
35
100
N02AC04
ATC
dextropropoxyphene; oral
3.6
10.4
36
108
J01MA12
ATC
levofloxacin; systemic
2.4
10.4
85
409
R06AX12
ATC
terfenadine; oral
5.1
10.4
22
45
C03CA01
ATC
furosemide; systemic
2.1
10.3
194
1296
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
9.5
10.1
20
22
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
3.3
10.1
39
126
J01DA09
ATC
[U] cefadroxil
2.2
9.8
104
558
C01AA05
ATC
digoxin; systemic
2.3
9.7
85
421
R05FA02
ATC
opium derivatives and expectorants; systemic
2.0
9.6
147
905
51899
ICD-8 Finland
Bronchiectasis
30.9
9.5
12
*
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
30.9
9.5
12
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.1
9.3
20
26
C08DA01
ATC
verapamil; systemic
3.5
9.1
33
102
R01AD05
ATC
budesonide; nasal
3.5
9.1
32
97
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
16.1
9.1
14
9
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.7
9.0
21
47
N06AB03
ATC
fluoxetine; oral
2.8
8.9
47
182
R06AX13
ATC
loratadine; oral
2.9
8.8
45
171
N05CF01
ATC
zopiclone; oral
2.0
8.7
154
992
R03DA05
ATC
aminophylline; systemic, rectal
10.4
8.6
16
16
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
92.1
8.4
9
*
R03AK11
ATC
formoterol and fluticasone; inhalant
13.2
8.4
14
11
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
11.1
8.4
15
14
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.4
8.1
30
94
R01AD01
ATC
beclometasone; nasal
2.6
8.1
52
223
L04AX03
ATC
methotrexate; systemic
22.6
8.1
11
5
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.1
8.0
22
56
G47.3
ICD-10 Finland
Sleep apnoea
2.4
8.0
57
257
J01MA01
ATC
ofloxacin; systemic
2.5
7.8
52
226
M01CB01
ATC
sodium aurothiomalate; parenteral
46.0
7.7
9
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.9
7.7
151
995
A02BA03
ATC
famotidine; systemic
3.3
7.7
29
92
R04.2
ICD-10 Finland
Haemoptysis
3.8
7.6
23
63
A02BC01
ATC
omeprazole; systemic
1.9
7.5
115
699
R01AD09
ATC
mometasone; nasal
1.9
7.5
113
683
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.0
7.5
109
651
A98
ICPC
Health maint/preventive medicine
0.5
7.5
165
2201
A12BA01
ATC
potassium chloride; oral
2.6
7.3
44
183
N05CD07
ATC
temazepam; oral
2.1
7.2
81
440
P01BA02
ATC
hydroxychloroquine; oral
4.5
7.0
17
39
R06AE09
ATC
levocetirizine; oral
2.8
7.0
35
132
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.5
7.0
24
72
R05CA10
ATC
expectorants - combinations
4.4
6.8
17
40
J01DC02
ATC
cefuroxime; systemic
4.4
6.8
17
40
A07EC01
ATC
sulfasalazine; oral, rectal
4.4
6.8
17
40
L04AX01
ATC
azathioprine; systemic
40.8
6.8
8
*
R03AK08
ATC
formoterol and beclometasone; inhalant
7.4
6.8
15
21
4224
FHL
Endonasal anthrostomy
12.6
6.6
11
9
7860A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]
8.9
6.6
13
15
A03FA02
ATC
cisapride; oral, rectal
2.5
6.5
44
193
N06AA12
ATC
doxepin; systemic
2.8
6.4
32
120
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.7
6.4
17
31
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
7.2
6.3
14
20
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
7.2
6.3
14
20
L04AA13
ATC
[U] leflunomide
+∞
6.3
6
*
H02AB09
ATC
hydrocortisone; systemic
7.9
6.2
13
17
R01AD11
ATC
triamcinolone; nasal
3.1
6.1
26
89
N02AX02
ATC
tramadol; systemic, rectal
1.8
6.1
144
989
N05BB01
ATC
hydroxyzine; systemic
2.8
6.1
30
112
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
23
70
3.44
6.53
4.2
2.6
—
—
—
0
0
151
2015
0.57
6.21
6.1
5.4
6.29
6.12
mmol/l
0.55
136
1787
9
7
13.14
5.61
6.3
3.4
—
—
—
0
0
158
2009
0.63
4.63
6.1
6.0
2.58
2.52
mmol/l
0.40
141
1796
29
124
2.45
4.54
2.0
1.3
—
—
—
0
0
35
163
2.27
4.54
3.5
2.5
118.43
125.07
g/l
0.97
35
158
154
1945
0.64
4.16
26.5
17.5
72.65
69.78
ml/min/173m2
0.91
148
1830
170
2101
0.64
4.14
33.2
16.4
25.36
28.12
mg/l
0.48
151
1743
157
1962
0.65
3.93
8.5
7.0
41.77
40.63
mmol/mol
0.57
142
1794
156
1945
0.66
3.81
5.4
5.1
4.61
4.45
mmol/l
1.33
140
1755
155
1929
0.66
3.70
5.4
5.0
1.54
1.48
mmol/l
0.79
137
1722
28
130
2.25
3.68
3.9
2.9
25.34
24.99
mmol/l
0.19
28
124
21
86
2.53
3.62
1.4
1.2
—
—
—
0
0
47
267
1.87
3.62
5.0
3.4
5.84
5.72
kpa
0.36
47
255
11
26
4.33
3.53
3.7
2.6
—
—
—
0
0
157
1936
0.67
3.48
6.5
5.3
1.95
2.03
mu/l
0.27
143
1717
149
1856
0.67
3.48
4.7
4.3
1.25
1.23
mmol/l
0.17
135
1635
7
10
7.11
3.38
10.7
1.1
—
—
u/ml
—
0
0
13
43
3.10
3.28
3.8
1.2
—
—
—
0
0
41
234
1.85
3.12
4.1
2.7
4.09
4.15
kpa
0.08
41
223
14
50
2.87
3.12
1.5
1.3
—
—
—
0
0
14
50
2.87
3.12
1.5
1.3
—
—
—
0
0
13
45
2.96
3.05
3.9
1.2
—
—
—
0
0
7
13
5.47
2.88
1.4
1.0
—
—
—
0
0
7
13
5.47
2.88
1.4
1.0
—
—
—
0
0
26
134
2.01
2.68
3.3
2.7
2.06
2.42
mmol/l
0.19
21
98
33
550
0.56
2.62
6.4
4.7
19.75
22.36
%
0.77
22
304
5
7
7.22
2.55
4.4
2.1
35.80
72.96
ug/l
—
5
7
10
31
3.29
2.53
4.3
1.4
—
—
—
0
0
11
38
2.95
2.43
4.0
1.1
—
—
—
0
0
19
91
2.15
2.37
2.1
1.6
—
—
—
0
0
28
156
1.86
2.33
5.8
3.5
38.98
43.03
%
0.43
28
151
9
28
3.27
2.32
1.2
1.3
—
—
—
0
0
9
28
3.27
2.32
4.3
1.4
—
—
—
0
0
30
173
1.80
2.25
2.4
1.5
—
—
—
0
0
17
84
2.07
1.99
1.8
1.5
—
—
—
0
0
5
11
4.59
1.94
6.8
1.0
—
—
—
0
0
5
13
3.88
1.72
2.6
1.2
—
—
—
0
0
5
13
3.88
1.72
2.6
1.2
—
—
—
0
0
5
13
3.88
1.72
1.6
1.3
—
—
—
0
0
41
282
1.51
1.61
10.8
5.2
1.77
1.03
mmol/l
0.47
35
225
139
1607
0.78
1.47
5.0
4.2
15.34
15.11
pmol/l
0.44
123
1407
9
38
2.40
1.46
4.7
1.1
—
—
—
0
0
7
28
2.53
1.46
2.1
1.4
—
—
—
0
0
11
52
2.15
1.46
3.8
1.2
—
—
—
0
0
137
1582
0.79
1.42
7.4
5.3
201.00
4031.93
e6/l
—
7
42
7
29
2.44
1.40
4.7
1.3
—
—
—
0
0
27
178
1.56
1.30
4.1
4.1
88.47
95.39
ng/l
0.14
22
151
83
674
1.30
1.26
2.7
2.2
3.25
3.19
mg/l
0.08
71
572
62
780
0.75
1.23
3.0
3.9
6.99
8.74
mg/mmol
0.14
42
481
61
768
0.75
1.22
1.9
1.9
1.22
1.26
mmol/l
0.16
51
615
6
26
2.33
1.19
1.8
1.1
—
—
—
0
0
5
20
2.52
1.15
2.4
1.2
—
—
—
0
0
5
20
2.52
1.15
2.4
1.2
—
—
—
0
0
57
447
1.33
1.11
2.9
1.7
—
—
—
0
0
22
144
1.56
1.11
1.5
1.4
—
—
—
0
0
5
21
2.40
1.09
2.4
1.1
—
—
—
0
0
5
22
2.29
1.03
1.4
1.1
—
—
—
0
0
19
283
0.65
1.01
6.5
8.5
—
—
—
0
0
0
32
0.00
0.95
0.0
1.9
—
—
—
0
0
6
28
2.16
0.92
1.3
1.3
0.77
0.91
g/l
—
6
28
40
510
0.76
0.89
4.8
3.4
308.39
186.31
ng/l
0.17
33
434
6
30
2.02
0.87
2.5
2.0
1.00
2.83
u/field
—
6
12
54
442
1.26
0.79
1.9
1.5
1.65
1.49
mg/l
0.10
43
360
67
789
0.82
0.78
2.0
1.8
29.73
20.40
nmol/l
0.83
59
655
6
34
1.78
0.76
1.8
1.1
—
—
—
0
0
98
1110
0.84
0.75
8.1
3.9
33.83
34.49
g/l
0.57
92
1020
43
345
1.28
0.75
11.0
5.2
104.12
104.52
mmol/l
0.15
43
345
7
38
1.86
0.74
2.0
1.1
0.72
0.79
nmol/l
—
7
30
7
40
1.76
0.71
6.1
2.6
12.41
10.46
pmol/l
—
7
40
5
27
1.86
0.68
1.4
1.3
1.72
1.61
g/l
—
5
27
157
1701
0.87
0.68
10.9
6.4
81.50
85.03
u/l
0.28
151
1565
146
1587
0.87
0.65
7.3
3.1
15.78
15.06
mm/h
0.22
136
1420
20
146
1.39
0.65
15.5
6.6
0.77
0.67
%
0.54
20
146
20
268
0.73
0.64
4.5
4.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
10
64
1.58
0.59
2.4
1.5
—
—
—
0
0
78
881
0.85
0.58
5.5
3.0
2.36
2.36
mmol/l
0.03
71
784
111
1221
0.87
0.58
6.7
4.3
0.00
6.61
estimate
0.50
23
284
9
61
1.49
0.54
1.0
1.4
—
—
—
0
0
107
971
1.14
0.53
3.0
2.3
84.67
80.27
nmol/l
0.75
100
847
40
334
1.22
0.52
2.9
1.6
—
—
—
0
0
20
153
1.32
0.51
15.3
6.4
1.43
1.35
%
0.21
20
153
34
407
0.82
0.49
1.4
1.2
1.87
1.24
u/ml
—
6
107
111
1207
0.88
0.48
6.7
4.2
0.00
0.00
estimate
-0.00
23
268
124
1144
1.13
0.48
12.2
6.5
4.79
4.15
e9/l
1.80
118
963
7
48
1.47
0.47
2.0
1.1
—
—
—
0
0
113
1225
0.89
0.46
6.7
4.2
0.19
1.15
estimate
0.39
21
263
109
1180
0.89
0.44
3.6
2.9
42.73
56.16
u/l
1.19
100
1080
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
87
951
0.89
0.41
7.1
4.4
0.00
0.06
estimate
1.41
20
216
82
898
0.89
0.40
5.2
3.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.7
—
795.22
—
0
18
104
1122
0.90
0.39
2.4
2.2
99.69
95.32
pmol/l
0.35
50
569
24
197
1.23
0.39
1.4
1.5
—
—
—
0
0
72
653
1.13
0.37
5.1
2.6
36.43
36.13
u/l
0.01
67
613
37
322
1.17
0.34
3.0
1.7
—
—
—
0
0
65
714
0.89
0.34
4.8
3.3
0.30
0.53
e6/l
0.90
55
532
13
166
0.78
0.34
3.8
3.0
60.00
58.00
ml/min/173m2
—
7
71
6
45
1.34
0.34
1.7
1.3
—
—
—
0
0
21
173
1.23
0.33
2.1
1.7
—
—
—
0
0
10
75
1.34
0.30
8.4
3.4
3.72
3.93
mmol/l
—
10
75
51
562
0.89
0.28
6.3
4.5
1.02
1.02
kg/l
0.06
34
370
24
206
1.18
0.27
2.7
2.9
148.58
241.80
ng/l
0.82
24
190
68
729
0.92
0.23
6.0
4.2
0.00
0.00
estimate
-0.00
19
231
106
1115
0.93
0.23
12.0
5.0
1.21
1.21
mmol/l
0.38
99
1003
45
412
1.11
0.21
4.3
3.1
1.70
1.42
e6/l
0.22
32
218
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
62
660
0.93
0.18
7.9
3.8
0.00
0.17
estimate
0.74
19
195
121
1257
0.94
0.18
11.8
5.3
1.22
1.21
mmol/l
0.21
105
1052
55
516
1.08
0.16
3.3
2.1
—
—
—
0
0
98
1022
0.94
0.16
5.7
4.4
158.32
77.52
ng/l
0.30
79
821
86
896
0.95
0.14
3.6
3.1
1489.66
2332.02
ng/l
1.56
80
766
98
945
1.05
0.13
4.6
2.9
108.97
133.29
ug/l
1.06
91
849
22
242
0.90
0.13
1.2
1.4
—
—
—
0
0
29
268
1.09
0.12
4.6
2.8
242.28
251.64
u/l
0.26
29
250
54
567
0.94
0.12
2.0
1.9
498.84
456.90
pmol/l
0.43
43
451
37
393
0.93
0.11
4.8
3.3
4.00
2.99
e6/l
0.22
23
200
11
97
1.14
0.09
7.7
3.7
1.52
1.38
mmol/l
0.18
11
97
24
257
0.93
0.09
5.3
5.1
37.93
32.67
%
0.94
15
158
7
65
1.08
0.08
1.9
1.1
—
—
—
0
0
7
65
1.08
0.08
1.9
1.1
—
—
—
0
0
8
76
1.05
0.07
1.4
1.4
0.00
0.00
g/l
—
8
69
8
76
1.05
0.07
1.4
1.4
0.57
0.00
g/l
—
8
70
56
542
1.04
0.07
2.0
1.8
1211.98
1185.65
nmol/l
0.07
41
408
28
294
0.95
0.06
1.3
1.2
25.31
20.67
iu/ml
—
7
92
93
941
0.98
0.02
3.0
2.3
—
—
—
0
0
99
982
1.01
0.01
4.2
2.6
—
—
estimate
—
0
0
120
1207
0.99
0.01
8.4
5.3
9.68
12.26
umol/l
2.08
115
1138
25
256
0.97
0.00
1.2
1.2
1.14
2.36
u/ml
—
10
79
38
378
1.01
0.00
2.8
1.6
28.45
29.53
s
0.70
38
368
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
5
50
1.00
0.00
3.4
1.5
—
—
—
0
0
8
79
1.01
-0.00
1.5
1.6
31.25
58.71
mg/l
—
8
68
0
6
0.00
-0.00
0.0
1.3
—
48.03
—
0
6
8
79
1.01
-0.00
1.5
1.6
27.09
124.38
mg/l
—
8
68
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
7
78
0.90
-0.00
1.9
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
10.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ILD_ASETYLCYSTEINE – ILD medications: acetylcysteine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).